Cargando…

Recovery of recombinant Mycobacterium tuberculosis antigens fused with cell wall-anchoring motif (LysM) from inclusion bodies using non-denaturing reagent (N-laurylsarcosine)

BACKGROUND: The current limitations of conventional BCG vaccines highlights the importance in developing novel and effective vaccines against tuberculosis (TB). The utilization of probiotics such as Lactobacillus plantarum for the delivery of TB antigens through in-trans surface display provides an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafa, Anhar Danial, Kalyanasundram, Jeevanathan, Sabidi, Sarah, Song, Adelene Ai-Lian, Abdullah, Maha, Abdul Rahim, Raha, Yusoff, Khatijah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518676/
https://www.ncbi.nlm.nih.gov/pubmed/31088425
http://dx.doi.org/10.1186/s12896-019-0522-x
_version_ 1783418503010713600
author Mustafa, Anhar Danial
Kalyanasundram, Jeevanathan
Sabidi, Sarah
Song, Adelene Ai-Lian
Abdullah, Maha
Abdul Rahim, Raha
Yusoff, Khatijah
author_facet Mustafa, Anhar Danial
Kalyanasundram, Jeevanathan
Sabidi, Sarah
Song, Adelene Ai-Lian
Abdullah, Maha
Abdul Rahim, Raha
Yusoff, Khatijah
author_sort Mustafa, Anhar Danial
collection PubMed
description BACKGROUND: The current limitations of conventional BCG vaccines highlights the importance in developing novel and effective vaccines against tuberculosis (TB). The utilization of probiotics such as Lactobacillus plantarum for the delivery of TB antigens through in-trans surface display provides an effective and safe vaccine approach against TB. Such non-recombinant probiotic surface display strategy involves the fusion of candidate proteins with cell wall binding domain such as LysM, which enables the fusion protein to anchor the L. plantarum cell wall externally, without the need for vector genetic modification. This approach requires sufficient production of these recombinant fusion proteins in cell factory such as Escherichia coli which has been shown to be effective in heterologous protein production for decades. However, overexpression in E. coli expression system resulted in limited amount of soluble heterologous TB-LysM fusion protein, since most of it are accumulated as insoluble aggregates in inclusion bodies (IBs). Conventional methods of denaturation and renaturation for solubilizing IBs are costly, time-consuming and tedious. Thus, in this study, an alternative method for TB antigen-LysM protein solubilization from IBs based on the use of non-denaturating reagent N-lauroylsarcosine (NLS) was investigated. RESULTS: Expression of TB antigen-LysM fusion genes was conducted in Escherichia coli, but this resulted in IBs deposition in contrast to the expression of TB antigens only. This suggested that LysM fusion significantly altered solubility of the TB antigens produced in E. coli. The non-denaturing NLS technique was used and optimized to successfully solubilize and purify ~ 55% of the recombinant cell wall-anchoring TB antigen from the IBs. Functionality of the recovered protein was analyzed via immunofluorescence microscopy and whole cell ELISA which showed successful and stable cell wall binding to L. plantarum (up to 5 days). CONCLUSION: The presented NLS purification strategy enables an efficient and rapid method for obtaining higher yields of soluble cell wall-anchoring Mycobacterium tuberculosis antigens-LysM fusion proteins from IBs in E. coli. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12896-019-0522-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6518676
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65186762019-05-21 Recovery of recombinant Mycobacterium tuberculosis antigens fused with cell wall-anchoring motif (LysM) from inclusion bodies using non-denaturing reagent (N-laurylsarcosine) Mustafa, Anhar Danial Kalyanasundram, Jeevanathan Sabidi, Sarah Song, Adelene Ai-Lian Abdullah, Maha Abdul Rahim, Raha Yusoff, Khatijah BMC Biotechnol Methodology Article BACKGROUND: The current limitations of conventional BCG vaccines highlights the importance in developing novel and effective vaccines against tuberculosis (TB). The utilization of probiotics such as Lactobacillus plantarum for the delivery of TB antigens through in-trans surface display provides an effective and safe vaccine approach against TB. Such non-recombinant probiotic surface display strategy involves the fusion of candidate proteins with cell wall binding domain such as LysM, which enables the fusion protein to anchor the L. plantarum cell wall externally, without the need for vector genetic modification. This approach requires sufficient production of these recombinant fusion proteins in cell factory such as Escherichia coli which has been shown to be effective in heterologous protein production for decades. However, overexpression in E. coli expression system resulted in limited amount of soluble heterologous TB-LysM fusion protein, since most of it are accumulated as insoluble aggregates in inclusion bodies (IBs). Conventional methods of denaturation and renaturation for solubilizing IBs are costly, time-consuming and tedious. Thus, in this study, an alternative method for TB antigen-LysM protein solubilization from IBs based on the use of non-denaturating reagent N-lauroylsarcosine (NLS) was investigated. RESULTS: Expression of TB antigen-LysM fusion genes was conducted in Escherichia coli, but this resulted in IBs deposition in contrast to the expression of TB antigens only. This suggested that LysM fusion significantly altered solubility of the TB antigens produced in E. coli. The non-denaturing NLS technique was used and optimized to successfully solubilize and purify ~ 55% of the recombinant cell wall-anchoring TB antigen from the IBs. Functionality of the recovered protein was analyzed via immunofluorescence microscopy and whole cell ELISA which showed successful and stable cell wall binding to L. plantarum (up to 5 days). CONCLUSION: The presented NLS purification strategy enables an efficient and rapid method for obtaining higher yields of soluble cell wall-anchoring Mycobacterium tuberculosis antigens-LysM fusion proteins from IBs in E. coli. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12896-019-0522-x) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-14 /pmc/articles/PMC6518676/ /pubmed/31088425 http://dx.doi.org/10.1186/s12896-019-0522-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology Article
Mustafa, Anhar Danial
Kalyanasundram, Jeevanathan
Sabidi, Sarah
Song, Adelene Ai-Lian
Abdullah, Maha
Abdul Rahim, Raha
Yusoff, Khatijah
Recovery of recombinant Mycobacterium tuberculosis antigens fused with cell wall-anchoring motif (LysM) from inclusion bodies using non-denaturing reagent (N-laurylsarcosine)
title Recovery of recombinant Mycobacterium tuberculosis antigens fused with cell wall-anchoring motif (LysM) from inclusion bodies using non-denaturing reagent (N-laurylsarcosine)
title_full Recovery of recombinant Mycobacterium tuberculosis antigens fused with cell wall-anchoring motif (LysM) from inclusion bodies using non-denaturing reagent (N-laurylsarcosine)
title_fullStr Recovery of recombinant Mycobacterium tuberculosis antigens fused with cell wall-anchoring motif (LysM) from inclusion bodies using non-denaturing reagent (N-laurylsarcosine)
title_full_unstemmed Recovery of recombinant Mycobacterium tuberculosis antigens fused with cell wall-anchoring motif (LysM) from inclusion bodies using non-denaturing reagent (N-laurylsarcosine)
title_short Recovery of recombinant Mycobacterium tuberculosis antigens fused with cell wall-anchoring motif (LysM) from inclusion bodies using non-denaturing reagent (N-laurylsarcosine)
title_sort recovery of recombinant mycobacterium tuberculosis antigens fused with cell wall-anchoring motif (lysm) from inclusion bodies using non-denaturing reagent (n-laurylsarcosine)
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518676/
https://www.ncbi.nlm.nih.gov/pubmed/31088425
http://dx.doi.org/10.1186/s12896-019-0522-x
work_keys_str_mv AT mustafaanhardanial recoveryofrecombinantmycobacteriumtuberculosisantigensfusedwithcellwallanchoringmotiflysmfrominclusionbodiesusingnondenaturingreagentnlaurylsarcosine
AT kalyanasundramjeevanathan recoveryofrecombinantmycobacteriumtuberculosisantigensfusedwithcellwallanchoringmotiflysmfrominclusionbodiesusingnondenaturingreagentnlaurylsarcosine
AT sabidisarah recoveryofrecombinantmycobacteriumtuberculosisantigensfusedwithcellwallanchoringmotiflysmfrominclusionbodiesusingnondenaturingreagentnlaurylsarcosine
AT songadeleneailian recoveryofrecombinantmycobacteriumtuberculosisantigensfusedwithcellwallanchoringmotiflysmfrominclusionbodiesusingnondenaturingreagentnlaurylsarcosine
AT abdullahmaha recoveryofrecombinantmycobacteriumtuberculosisantigensfusedwithcellwallanchoringmotiflysmfrominclusionbodiesusingnondenaturingreagentnlaurylsarcosine
AT abdulrahimraha recoveryofrecombinantmycobacteriumtuberculosisantigensfusedwithcellwallanchoringmotiflysmfrominclusionbodiesusingnondenaturingreagentnlaurylsarcosine
AT yusoffkhatijah recoveryofrecombinantmycobacteriumtuberculosisantigensfusedwithcellwallanchoringmotiflysmfrominclusionbodiesusingnondenaturingreagentnlaurylsarcosine